Anthony Marchand1, Lucia Bonati1,2, Sailan Shui1

  • 1Laboratory of Protein Design and Immunoengineering, Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.

PubMed
概括

科学家们开发了可切换的蛋白质疗法,以更好地控制. 添加特定药物很快就会使这些生物药物失活,减少副作用,并在瘤学和自身免疫性疾病中扩大治疗潜力.